Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) has recently announced an amendment to its first lien credit agreement’s revolving credit facility, extending the facility's maturity date to April 2028. The amendment also specifies that the maximum borrowing availability under the revolver is currently $170.33 million until April 2026. Subsequently, following the unamended maturity date in April 2026, the maximum borrowing availability under the revolver will be $148.85 million.
Matt Buckhalter, the Chief Financial Officer of Aveanna, expressed satisfaction with the extension, emphasizing that the revolving credit facility provides ample liquidity for the company to invest in growth and maintain the delivery of high-quality, value-based care in the home. He also conveyed confidence in the company's balance sheet and expressed gratitude to their credit partners for their trust.
The company is scheduled to report its third-quarter earnings on Thursday, November 7, 2024. For additional information, the company has filed a current report on Form 8-K with the Securities and Exchange Commission. The market has reacted to these announcements by moving the company's shares 0.0% to a price of $4.53. Check out the company's full 8-K submission here.
